Back to search
Æ-941, an inhibitor of angiogenesis: rationale for development in combination with induction chemotherapy/radiotherapy in patients with non-small-cell lung cancer (nsclc)
Data up to Jan 2025
Published1999
Citations11
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...